Trial Profile
Study of teneligliptin in patients with type 2 diabetes mellitus (T2DM)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 08 Jul 2016 New trial record
- 28 Jun 2016 Results published in the Clinical Drug Investigation